Multiple novel agents with diverse mechanisms of action are currently in development to overcome resistance to endocrine therapy (ET) and CDK4/6 inhibitors in hormone receptor–positive breast cancer.

FM Nirmala Sitharaman at a fireside chat on ET Awards night At a time when India's trade equations face a very uncertain situation, India will need to keep its supply chains robust -- and that is the ...

All reviews are written independently by our editorial team. Marine veteran and former CIA officer Elliot Ackerman is the best-selling author of several novels and memoirs. His most recent book ...

What makes this low-earth orbit satellite technology so revolutionary, and how might it transform India’s telecom sector? And will this tie up, which clearly has larger geopolitical implications, ...

The New York Times' Tyler Pager joins Morning Joe to discuss his new reporting on Steve Bannon, Elon Musk and the battle within MAGA.March 10, 2025 ...

Liverpool have been scouring the market for a left-back to replace 31-year-old Scot Andy Robertson with Bournemouth's Hungary defender Milos Kerkez, 21, one of their main targets. Newcastle ...